Form 4: Imunon Executive Chairman Acquires Shares

Imunon, Inc. reports that Executive Chairman Michael H. Tardugno acquired 4,410 shares of common stock on July 2, 2026, valued at $1.91 per share, as compensation for services.

Summary

• Michael H. Tardugno, Executive Chairman of Imunon, Inc., acquired 4,410 shares of common stock on July 2, 2026.
• The shares were granted in lieu of cash for base salary.
• The acquisition price was $1.91 per share.
• Following this transaction, Mr. Tardugno beneficially owns 64,396 shares, with 4,622 held indirectly through an IRA.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider receiving compensation in stock, which can align interests, but it does not provide new financial performance data.

Positives

• Executive Chairman Michael H. Tardugno received shares as compensation, indicating a commitment to aligning executive interests with shareholder value.
• The acquisition of 4,410 shares at $1.91 per share suggests a belief in the company's valuation at this price point.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, especially when granted in lieu of cash compensation, can be viewed positively by the market as they signal management's confidence in the company's future prospects and align their interests with those of other shareholders.

Stakeholder Impact

• Shareholders: The acquisition by an executive chairman can be seen as a positive signal of confidence in the company's future, potentially aligning executive and shareholder interests.
• Employees: Receiving stock as compensation can be a motivational tool for executives.
• Management: The transaction details the compensation structure for the Executive Chairman.

Key Dates

Keywords

Imunon Inc, IMNN, Form 4, SEC Filing, Insider Transaction, Stock Acquisition, Executive Compensation, Beneficial Ownership